Avego Healthcare Capital logo

Avego Healthcare Capital

North America, Georgia, United States, Alpharetta

Description

Avego Healthcare Capital is a private equity firm focused in the healthcare sector.

Investor Profile

Avego Healthcare Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series C (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Medical
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Avego Healthcare Capital frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
Metalmark Capital
North America, New York, United States, New York
Co-Investments: 1
Qiming Venture Partners USA
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Amgen
North America, California, United States, Thousand Oaks
Co-Investments: 1
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Apeiron Investment Group
Europe, NA - Malta, Malta, Sliema
Co-Investments: 1
Kingdon Capital
North America, New York, United States, New York
Co-Investments: 1
FK
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 1

What are some of recent deals done by Avego Healthcare Capital?

Jasper Therapeutics

Redwood City, California, United States

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquitySep 27, 2021
Amount Raised: $100,000,000
Arch Oncology

St Louis, Missouri, United States

Arch Oncology is a venture-stage biopharmaceutical company.

BiotechnologyMedicalOncologyTherapeutics
Series CApr 27, 2021
Amount Raised: $105,000,000